Skip to main content
IART
NASDAQ Life Sciences

Integra LifeSciences Raises Full-Year EPS Outlook, Citi Lifts PT to $16

Tom Rudovsky · Reported by Wiseek News
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$16.46
Mkt Cap
$1.281B
52W Low
$8.7
52W High
$16.62
52W Position info
89% above low
Off High info
at 52W high
Rel. Volume info
1.4× avg
Market data snapshot near publication time

IART sits 89% above its 52-week low of $8.7.

Summary

Integra LifeSciences has raised its full-year 2026 adjusted EPS outlook to $2.40–$2.50. This positive revision follows the company's Q1 2026 results, which reported adjusted EPS of $0.54 and revenue of $391.9 million, as previously disclosed on May 5th. The increased guidance signals improved future performance expectations from management. In response, Citigroup has raised its price target for IART to $16 from $11 and upgraded its rating to Neutral.

At the time of this announcement, IART was trading at $16.46 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $8.70 to $16.62. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IART - Latest Insights

IART
Oct 21, 2026, 1:00 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $12.43
Real-time Price: $13.76 info
Change: +$1.33 (+11%) info
Market Cap: $1.072B info
IART
Oct 21, 2026, 6:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $13.76 info
Change: +$0.510 (+4%) info
Market Cap: $1.072B info
IART
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $13.25
Real-time Price: $13.76 info
Change: +$0.510 (+4%) info
Market Cap: $1.072B info
IART
Oct 19, 2026, 4:20 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.45
Real-time Price: $13.76 info
Change: +$0.310 (+2%) info
Market Cap: $1.072B info
IART
Oct 09, 2026, 5:26 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.44
Real-time Price: $13.76 info
Change: +$0.320 (+2%) info
Market Cap: $1.072B info